The only thing I am waiting for a clear line in the sand. Want to have revenue forecasts from management.
IMO a partnership is worthless unless Management decides that market guidance must also be disclosed as part of the announcement.
It’s great that the company has given go live dates but also give estimates...
a few companies RAP included has been guilty of just going for the head line.
So I ask TK how many consultations does Couvi and Phoenix do that are respiratory related and how many times will they expect to utilise RAP tech???
if you can not give that detail it’s hot air... I put a buy order in today for RSH which got partially filled given the detail they have given on their timelines and key milestones that have to delivered and by when.
if RAP can come out before their 4C with some revenue guidance or at least key assumptions that they have built their internal company model off I will buy... as previously stated I am happy to mop up but I am waiting for 10-12 cents.
ALL IMO DYOR...
ps 30 plus posts in a day I am just in the zone wanting to get as many data points from as many different people I do this when I push the button on trades... Here for the long term!
- Forums
- ASX - By Stock
- RAP
- Ann: Change of Director's Interest Notice
Ann: Change of Director's Interest Notice, page-60
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
-
- There are more pages in this discussion • 145 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)